What is Utah Medical Products's additional paid-in capital?

Utah Medical Products (UTMD) reported additional paid-in capital of $0 in Q1 2026.

What is the long-term trend for Utah Medical Products's additional paid-in capital?

Over 5 years (2020 to 2025), Utah Medical Products's additional paid-in capital has grown at a -100.0% compound annual growth rate (CAGR), from $115K to $0.

What does additional paid-in capital mean?

Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.

Utah Medical Products UTMD Additional Paid-In Capital

Additional Paid-In Capital at other companies

TFX

TeleflexTFX

$815.81M+4.4%

The Cooper Companies, Inc.COO

$1.98B+2.1%

IAR

Integra LifeSciencesIART

$1.34B+1.3%

Pediatrix Medical GroupMD

$931.26M-8.4%

UFP TechnologiesUFPT

$45.09M+14.6%

InfuSystem HoldingsINFU

$118.71M+3.3%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's additional paid-in capital?: Utah Medical Products (UTMD) reported additional paid-in capital of $0 in Q1 2026.
What is the long-term trend for Utah Medical Products's additional paid-in capital?: Over 5 years (2020 to 2025), Utah Medical Products's additional paid-in capital has grown at a -100.0% compound annual growth rate (CAGR), from $115K to $0.
What does additional paid-in capital mean?: Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.